Saara‐Anne Azizi

1.9k total citations
18 papers, 678 citations indexed

About

Saara‐Anne Azizi is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Saara‐Anne Azizi has authored 18 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Saara‐Anne Azizi's work include Peptidase Inhibition and Analysis (4 papers), Click Chemistry and Applications (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Saara‐Anne Azizi is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Click Chemistry and Applications (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Saara‐Anne Azizi collaborates with scholars based in United States, Portugal and India. Saara‐Anne Azizi's co-authors include Donald J. Woodward, Barry D. Waterhouse, Richard A. Burne, Bryan C. Dickinson, Rahul S. Kathayat, Pedro M. P. Góis, Allyson M. Freedy, Pedro M. S. D. Cal, Padma Akkapeddi and Gonçalo J. L. Bernardes and has published in prestigious journals such as Accounts of Chemical Research, Brain Research and Nature Chemistry.

In The Last Decade

Saara‐Anne Azizi

18 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saara‐Anne Azizi United States 12 350 139 122 117 94 18 678
Barry Burnette United States 13 508 1.5× 295 2.1× 108 0.9× 68 0.6× 59 0.6× 19 916
Roger Bossé Canada 18 625 1.8× 291 2.1× 85 0.7× 41 0.4× 32 0.3× 32 1.1k
Brigitte Maurer Germany 14 603 1.7× 88 0.6× 139 1.1× 82 0.7× 20 0.2× 19 1.1k
Daniel Langenegger Switzerland 19 796 2.3× 260 1.9× 169 1.4× 55 0.5× 225 2.4× 33 1.2k
Lars O. Hansson Sweden 14 687 2.0× 195 1.4× 303 2.5× 48 0.4× 67 0.7× 22 1.0k
Elizabeth Donohue Canada 14 687 2.0× 241 1.7× 93 0.8× 38 0.3× 85 0.9× 14 1.3k
Anamika Banerjee United States 14 419 1.2× 197 1.4× 146 1.2× 77 0.7× 43 0.5× 21 752
Eric J Miller United States 14 298 0.9× 129 0.9× 105 0.9× 32 0.3× 43 0.5× 27 615
Yajun Zhang China 15 413 1.2× 167 1.2× 47 0.4× 52 0.4× 24 0.3× 48 732
Xuan Zhao China 13 1.1k 3.2× 95 0.7× 302 2.5× 59 0.5× 68 0.7× 40 1.4k

Countries citing papers authored by Saara‐Anne Azizi

Since Specialization
Citations

This map shows the geographic impact of Saara‐Anne Azizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saara‐Anne Azizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saara‐Anne Azizi more than expected).

Fields of papers citing papers by Saara‐Anne Azizi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saara‐Anne Azizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saara‐Anne Azizi. The network helps show where Saara‐Anne Azizi may publish in the future.

Co-authorship network of co-authors of Saara‐Anne Azizi

This figure shows the co-authorship network connecting the top 25 collaborators of Saara‐Anne Azizi. A scholar is included among the top collaborators of Saara‐Anne Azizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saara‐Anne Azizi. Saara‐Anne Azizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Azizi, Saara‐Anne, et al.. (2025). Dynamic PRDX S-acylation modulates ROS stress and signaling. Cell chemical biology. 32(3). 511–519.e5. 2 indexed citations
2.
Azizi, Saara‐Anne, et al.. (2024). The glymphatic system and cerebral small vessel disease. Journal of Stroke and Cerebrovascular Diseases. 33(3). 107557–107557. 24 indexed citations
3.
Azizi, Saara‐Anne, et al.. (2024). Bioorthogonal masked acylating agents for proximity-dependent RNA labelling. Nature Chemistry. 16(5). 717–726. 21 indexed citations
4.
Azizi, Saara‐Anne, et al.. (2023). Regulation of ERK2 activity by dynamic S-acylation. Cell Reports. 42(9). 113135–113135. 6 indexed citations
5.
Azizi, Saara‐Anne, et al.. (2023). Molecular Glue Discovery: Current and Future Approaches. Journal of Medicinal Chemistry. 66(14). 9278–9296. 71 indexed citations
6.
Azizi, Saara‐Anne, et al.. (2022). A High-Throughput Fluorescent Turn-On Assay for Inhibitors of DHHC Family Proteins. ACS Chemical Biology. 17(8). 2018–2023. 6 indexed citations
7.
Azizi, Saara‐Anne, et al.. (2022). Charting the Chemical Space of Acrylamide-Based Inhibitors of zDHHC20. ACS Medicinal Chemistry Letters. 13(10). 1648–1654. 13 indexed citations
8.
Gupta, Yash, Sumit Kumar, Samantha E. Zak, et al.. (2021). Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. Bioorganic & Medicinal Chemistry. 47. 116393–116393. 15 indexed citations
9.
Gupta, Yash, Samantha E. Zak, Krysten A. Jones, et al.. (2021). Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays. Methods. 195. 57–71. 27 indexed citations
10.
Azizi, Saara‐Anne, et al.. (2021). Development of an Acrylamide-Based Inhibitor of Protein S -Acylation. ACS Chemical Biology. 16(8). 1546–1556. 41 indexed citations
11.
Azizi, Saara‐Anne, et al.. (2021). A System for the Evolution of Protein–Protein Interaction Inducers. ACS Synthetic Biology. 10(8). 2096–2110. 9 indexed citations
12.
Azizi, S. Ausim & Saara‐Anne Azizi. (2020). Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells. Journal of NeuroVirology. 26(5). 631–641. 33 indexed citations
13.
Cao, Yang, Rahul S. Kathayat, Saara‐Anne Azizi, et al.. (2019). ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5. Nature Chemical Biology. 15(12). 1232–1240. 93 indexed citations
14.
Azizi, Saara‐Anne, Rahul S. Kathayat, & Bryan C. Dickinson. (2019). Activity-Based Sensing of S-Depalmitoylases: Chemical Technologies and Biological Discovery. Accounts of Chemical Research. 52(11). 3029–3038. 25 indexed citations
15.
Akkapeddi, Padma, Saara‐Anne Azizi, Allyson M. Freedy, et al.. (2016). Construction of homogeneous antibody–drug conjugates using site-selective protein chemistry. Chemical Science. 7(5). 2954–2963. 126 indexed citations
16.
Akkapeddi, Padma, Saara‐Anne Azizi, Allyson M. Freedy, et al.. (2016). ChemInform Abstract: Construction of Homogeneous Antibody—Drug Conjugates Using Site‐Selective Protein Chemistry. ChemInform. 47(25). 3 indexed citations
17.
Waterhouse, Barry D., Saara‐Anne Azizi, Richard A. Burne, & Donald J. Woodward. (1990). Modulation of rat cortical area 17 neuronal responses to moving visual stimuli during norepinephrine and serotonin microiontophoresis. Brain Research. 514(2). 276–292. 160 indexed citations
18.
Azizi, Saara‐Anne, R. J. Kosinski, D.J. Woodward, & Gregory A. Mihailoff. (1986). Discrete receptive fields and physiological properties of neurons within the basilar pons correlation between direct peripheral and cortical inputs. The Society for Neuroscience Abstracts. 12(2). 1417. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026